This is the authors' abstract. We don't add key points for this paper.
T cell acute lymphoblastic leukemias (T-ALLs) arise from the malignant transformation of hematopoietic progenitors primed toward T cell development, as result of a multistep oncogenic process involving constitutive activation of NOTCH signaling and genetic alterations in transcription factors, signaling oncogenes, and tumor suppressors. Notably, these genetic alterations define distinct molecular groups of T-ALL with specific gene expression signatures and clinicobiological features. This review summarizes recent advances in our understanding of the molecular genetics of T-ALL.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Vlierberghe et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: